Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · IEX Real-Time Price · USD
12.80
+0.27 (2.15%)
At close: Mar 28, 2024, 3:48 PM
12.30
-0.50 (-3.91%)
After-hours: Mar 28, 2024, 4:40 PM EDT

Addex Therapeutics Cash Flow Statement

Millions CHF. Fiscal year is Jan - Dec.
Year 202220212020201920182017
Net Income
-20.8-15.35-12.86-14.78-1.64-3.28
Depreciation & Amortization
0.320.350.380.3300.02
Other Operating Activities
4.040.30.34.963.391.13
Operating Cash Flow
-16.44-14.71-12.18-9.481.75-2.14
Capital Expenditures
-0-0.03-0.06-0.03-0.01-0
Change in Investments
000-0.01-0.050
Investing Cash Flow
0-0.03-0.06-0.04-0.06-0
Share Issuance / Repurchase
1.1213.570.720.0140.483.36
Debt Issued / Paid
-0.29-0.31-0.37-0.3200
Other Financing Activities
2.273.14-0.31-0.15-3.1-0
Financing Cash Flow
3.116.40.05-0.4637.393.36
Exchange Rate Effect
-0.20.12-0.65-0.140.01-0.05
Net Cash Flow
-13.331.67-12.19-9.9939.081.21
Free Cash Flow
-16.44-14.74-12.24-9.511.74-2.14
Free Cash Flow Margin
-1137.59%-467.34%-315.52%-335.63%26.00%-428.19%
Free Cash Flow Per Share
-52.08-66.31-55.03-43.087.89-
Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).